Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma as Uva Cancer Center Doses Its First Patient
Shuttle Pharma擴大了Ropidoxuridine用於治療膠質母細胞瘤患者的第二階段臨床試驗的患者招募，烏瓦癌症中心爲其第一患者注射了劑量。
